Stance Capital’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$486K Sell
30,587
-232,740
-88% -$3.61M 0.15% 135
2026
Q1
$3.56M Buy
+263,327
New +$3.69M 1.73% 12
2025
Q3
Sell
-227,939
Closed -$2.04M 310
2025
Q2
$2.04M Sell
227,939
-78,818
-26% -$666K 0.77% 31
2025
Q1
$2.67M Buy
306,757
+190,561
+164% +$2M 1.98% 23
2024
Q4
$1.45M Buy
+116,196
New +$1.43M 0.9% 36

Other funds holding VTRS

Stance Capital's VTRS Position: Q2 2026 in Review

Stance Capital reduced its Viatris (VTRS) stake by 88% in Q2 2026, selling an estimated $3.61M and leaving 30,587 shares worth $486K. The position accounts for 0.15% of the portfolio, ranked #135.

Stance Capital first reported a position in VTRS in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.56M in Q1 2026. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Stance Capital held 30,587 shares of Viatris worth $486K as of Q2 2026.
  • Stance Capital sold 232,740 Viatris shares in Q2 2026, an estimated $3.61M.
  • Viatris made up 0.15% of Stance Capital's portfolio in Q2 2026, its #135 holding.
  • Stance Capital first reported a position in Viatris in Q4 2024 and has held it in 5 quarters since.
  • Stance Capital's Viatris position peaked at $3.56M in Q1 2026.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.